SCHEMBL659606

SCHEMBL659606

Fc1cc2ccsc2cn1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 1/20 0.38
CYP2A6 P11509 4/20 0.37
KDM4E B2RXH2 2/20 0.37
CYP2B6 P20813 2/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C19 P33261 1/20 0.37
GRM4 Q14833 1/20 0.37
MAPT P10636 2/20 0.35
ALDH1A1 P00352 1/20 0.35
HPGD P15428 1/20 0.35
PPARG P37231 1/20 0.35
HTT P42858 1/20 0.35
NCOA2 Q15596 1/20 0.35
NCOA1 Q15788 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
NCOA3 Q9Y6Q9 1/20 0.35
LMNA P02545 1/20 0.34
PTPRC P08575 1/20 0.34
PTPN6 P29350 1/20 0.34
PTPN11 Q06124 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8114596 0.75 DYRK1A (0.38) DYRK1ACYP2A6KDM4EGRM4MAPT
SCHEMBL660629 0.75 DYRK1A (0.38) DYRK1ACYP2A6KDM4EGRM4MAPT
SCHEMBL157982 0.75 CYP2A6 (0.47) DYRK1ACYP2A6KDM4EGRM4MAPT
SCHEMBL657606 0.75 DYRK1A (0.50) DYRK1ACYP2A6KDM4EGRM4MAPT
SCHEMBL659466 0.75 GRM4 (0.40) DYRK1ACYP2A6KDM4EGRM4MAPT
SCHEMBL18237423 0.71 KDM1A (0.39) DYRK1ACYP2A6KDM4EGRM4MAPT
SCHEMBL21666073 0.71 KDM4E (0.38) DYRK1ACYP2A6KDM4EGRM4MAPT
SCHEMBL22430462 0.71 KDM4E (0.41) DYRK1ACYP2A6KDM4EGRM4MAPT
SCHEMBL20631749 0.71 KDM4E (0.41) DYRK1ACYP2A6KDM4EGRM4MAPT
SCHEMBL12749940 0.71 KDM4E (0.38) DYRK1ACYP2A6KDM4EGRM4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8378104-B2 7-aminofuropyridine derivatives OSI Pharmaceuticals, LLC (US) 2013-02-19 US disclosed
EP-2534156-A1 7-AMINOFUROPYRIDINE DERIVATIVES OSI Pharmaceuticals, LLC (US) 2012-12-19 EP disclosed
US-20120046267-A1 7-AMINOFUROPYRIDINE DERIVATIVES OSI PHARMACEUTICALS, INC. 2012-02-23 US disclosed
WO-2011100502-A1 7-AMINOFUROPYRIDINE DERIVATIVES OSI Pharmaceuticals, LLC (US) 2011-08-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046267-A1 7-AMINOFUROPYRIDINE DERIVATIVES MAP3K5, STK17A, MAPKAPK5 DYRK1A 2154/4885CYP2A6 1912/4885KDM4E 117/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.